As innovations and discoveries in cancer immunotherapies progress at lightning speed, it is critical to understand the successes and challenges with current immunotherapies to separate the hype from the real opportunities.
IBC's Immuno-Oncology event develops tactics for improving the efficacy and response rates with first generation immunotherapies and builds a strategy for utilizing combination therapies, t-cell therapies, and checkpoint inhibitors to propel the next wave of cancer immunotherapies.
Advancing the Next Generation of Cancer Immunotherapies
September 31-October 1, 2015
Hilton Alexandria Marks Center
Download the Immuno-Oncology brochure now to create your pathway for an answer to cancer: http://bit.ly/1KB4Nkg
Register today and explore the latest advances in Immuno-Oncology to:
- Develop next generation immunotherapies by understanding recent advances made with CAR-T and T-Cell therapies, checkpoint inhibitors, cancer vaccines, and agnostic antibodies
- Create a successful combination therapy strategy by gaining insights from global leaders on effective combinations
Optimize the discovery and development of your promising immunotherapies by hearing best practices and lessons learned from the first wave of cancer immunotherapies.
We hope to see you this fall!
Register by June 19th and save up to $400: http://bit.ly/1KB4Nkg
The Immuno-Oncology Team
Share this article with your social network, just click below to share now!